Elekta to Showcase Leksell Gamma Knife Registry at AANS Annual Meeting
Cloud-based solution allows physicians to harness radiosurgery big data
ATLANTA – At the American Association of Neurological Surgeons (AANS) Annual Meeting, May 2-6 in Washington D.C., Elekta will highlight Leksell Gamma Knife® Registry, a solution that enables clinicians to leverage the enormous amount of data - generated by thousands of Gamma Knife radiosurgery treatments conducted each year - to advance clinical research and further optimize patient care.
"Gamma Knife Registry is a cloud-based solution that allows practitioners to store, retrieve, and analyze Gamma Knife radiosurgery treatment data*, as well as patient outcomes and operational information in a common format," says Catherine Gilmore-Lawless, Elekta Vice President, Clinical Intelligence. "By enabling uniform data entry and indication-specific analysis of Gamma Knife radiosurgery outcomes, clinicians now have a powerful tool to expand the use of this proven technology for more indications."
Currently deployed at several top academic medical centers, Leksell Gamma Knife Registry aims to:
• Identify global treatment patterns with Leksell Gamma Knife, and connections between treatment parameters and outcomes
• Provide integrated longitudinal data that could help clinicians develop insights to better select patients, personalize the treatment paradigm, and improve quality
• Advance collaboration in clinical research
"As a part of Elekta's Knowledge Management solution, Gamma Knife Registry is critical to deliver on our vision of Information-guided care™," says Richard Stark, Senior Vice President, Elekta Software. "Gamma Knife Registry allows users to better aggregate, analyze and gather insights needed to deliver the most effective and personalized care for each patient. Users can share their experiences in optimizing Gamma Knife treatments to make better-informed clinical decisions for their patients' care and increase quality and efficiency in their practices. The underlying goal is to drive better patient outcomes."
Leksell Gamma Knife Registry encompasses a secure HIPAA-compliant data warehouse and advanced indication specific analytics. Aggregated, de-identified data can be used for studies undertaken by the global Gamma Knife community. Interactive, self-service dashboards for visual discovery and reports are included, in addition to Leksell Gamma Knife® Society statistical reports.
Collaborative development
Registry development was a joint effort between Elekta and renowned Gamma Knife centers, including the University of Pittsburgh Medical Center, and veteran Gamma Knife radiosurgery practitioners, notably, Douglas Kondziolka, MD, Professor of Neurosurgery and Radiation Oncology at New York University School of Medicine.
"Our goal was to create new data sets, specific for Gamma Knife radiosurgery that are updated continuously and securely over the web," Dr. Kondziolka says. "This will allow clinicians to obtain data queries in real time to benchmark their own data with those nationally or globally. Importantly, underlying these high level views is a rich database with detailed treatment and follow-up data, which is ideally suited for research. Imagine basing a study on not 50 or 100 patients, but 10,000 or 50,000 patients on these 'Big Data' verified data sets. With that kind of powerful information, we may be able to really effect change in medicine."
Elekta supports the National SRS Brain Registry, a joint effort by the American Society for Radiation Oncology (ASTRO) and AANS which seeks to define national patterns of care in radiosurgery with an eye toward improving health care outcomes, supporting informed decision making and potentially lowering the cost-of-care delivery to patients. Elekta's Gamma Knife Registry will be utilized by participants to collect and provide data to the national effort.
To learn more about Leksell Gamma Knife Registry, visit www.elekta.com/LGKRegistry.
*Data, including protected health information, will be stored in the United States.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
SOURCE Elekta
Web Site: http://www.elekta.com
